{
  "subset": "indication",
  "disease": "Severe hypertriglyceridaemia",
  "relation": "indication",
  "gold_drugs": [
    "epanova",
    "gemcabene",
    "k-877",
    "olive oil",
    "omefas",
    "pegozafermin"
  ],
  "seeds_initial": [
    "Omega-3 fatty acids",
    "Icosapent ethyl",
    "Fibrates",
    "Fenofibrate",
    "Statins",
    "Niacin",
    "Ezetimibe",
    "Gemfibrozil",
    "Acipimox",
    "Lomitapide",
    "Bempedoic acid",
    "Orlistat"
  ],
  "seed_history": [
    [
      "Omega-3 fatty acids",
      "Icosapent ethyl",
      "Fibrates",
      "Fenofibrate",
      "Statins",
      "Niacin",
      "Ezetimibe",
      "Gemfibrozil",
      "Acipimox",
      "Lomitapide",
      "Bempedoic acid",
      "Orlistat"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_omega_3_fatty_acids",
          "name": "Omega-3 fatty acids"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Omega-3 针对高甘油三酯有显著的作用机制",
          "与 Proponent 的支持信号一致"
        ],
        "caveats": [
          "存在潜在的副作用和不良反应风险"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_icosapent_ethyl",
          "name": "Icosapent ethyl"
        },
        "score": 0.7,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Icosapent 在临床试验中显示有效性",
          "与 Proponent 的支持信号一致"
        ],
        "caveats": [
          "出血等副作用的风险需关注"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_fibrates",
          "name": "Fibrates"
        },
        "score": 0.55,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Fibrates 是传统治疗高甘油三酯的药物",
          "与 Proponent 的支持信号一致"
        ],
        "caveats": [
          "肝损伤的风险不容忽视"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_fenofibrate",
          "name": "Fenofibrate"
        },
        "score": 0.5,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "Fenofibrate 被认可为有效治疗高甘油三酯的药物",
          "与 Proponent 的支持信号一致"
        ],
        "caveats": [
          "可能造成肾功能损伤"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H5",
        "candidate": {
          "id": "drug_statins",
          "name": "Statins"
        },
        "score": 0.45,
        "graph_snapshot_ref": "GE_H5_round4",
        "key_assumptions": [
          "Statins 可以降低甘油三酯",
          "与 Proponent 的支持信号一致"
        ],
        "caveats": [
          "肌病的可能性需关注"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Targets→Phenotypes",
          "reason": "机制支持与反对信号共同存在，需进一步的证据支持"
        }
      ],
      "remaining_gaps": [
        "机制连接缺乏，可能影响评分依据的稳定性"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B"
          ],
          "impact_summary": "优化了早期假设的指标，但机制支持不足"
        }
      ],
      "lessons": [
        "对药物作用机制的验证需更为严格",
        "各候选药物可能存在重叠且需细化分类"
      ]
    },
    "prompt_patches": [],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that could be indicated for the rare disease 'Severe hypertriglyceridaemia'. Return only names.\n\n# Prior guidance for Explorer:\n- 关注增加多样性疗法以补偿潜在风险，避免重复已有候选。\n\n# Heuristics:\n- When 高甘油三酯胺: then 优先考虑具有明确机制且已有临床数据支持的药物。\n- When 对比疗效: then 考虑长期安全性和耐受性作为替代疗法的关键因素。"
}